Why We Have to Use Cardiac Resynchronization Therapy-Pacemaker More

Area of Science:

• Cardiology
• Medical Devices

Background:

• Cardiac resynchronization therapy (CRT) using a pacemaker (CRT-P) or a biventricular implantable cardioverter-defibrillator (CRT-D) is established for chronic heart failure.
• The clinical indications and cost-effectiveness of CRT-D versus CRT-P require careful consideration.

Purpose of the Study:

• To evaluate the current evidence supporting the universal prescription of CRT-D for heart failure patients.
• To discuss the appropriate selection criteria for CRT-P and CRT-D devices.
• To explore potential strategies for device management, such as downgrading from CRT-D to CRT-P.

Main Methods:

• Review of existing scientific literature on CRT-P and CRT-D efficacy and patient selection.
• Analysis of clinical guidelines and expert consensus regarding device implantation.
• Consideration of device longevity and patient outcomes.

Main Results:

• Limited scientific evidence supports the routine use of CRT-D in all eligible heart failure patients.
• CRT-P remains an acceptable therapeutic option.
• Downgrading from CRT-D to CRT-P at battery depletion is a potential strategy for selected patients with significant reverse remodeling and no history of ventricular arrhythmias.

Conclusions:

• The choice between CRT-P and CRT-D should be individualized based on clinical evidence and patient factors, not solely on device type.
• Cost and complexity of CRT-D warrant judicious prescription.
• Further research into device downgrading strategies could optimize patient management and resource utilization.